These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23167155)

  • 1. Early cardiac resynchronization therapy (CRT) improves the outcome in heart failure (HF) patients with left bundle branch block (LBBB).
    Stanislao M; Facciorusso A; Michelini S; de Luca G; Fanelli M; Valle G
    Monaldi Arch Chest Dis; 2012 Jun; 78(2):109-10. PubMed ID: 23167155
    [No Abstract]   [Full Text] [Related]  

  • 2. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.
    Engels EB; Végh EM; Van Deursen CJ; Vernooy K; Singh JP; Prinzen FW
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):176-83. PubMed ID: 25230363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy.
    Tian Y; Zhang P; Li X; Gao Y; Zhu T; Wang L; Li D; Wang J; Yuan C; Guo J
    Europace; 2013 Oct; 15(10):1499-506. PubMed ID: 23468351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy.
    Perrin MJ; Green MS; Redpath CJ; Nery PB; Keren A; Beanlands RS; Birnie DH
    Europace; 2012 May; 14(5):690-5. PubMed ID: 22170897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Linde C; Curtis AB; Fonarow GC; Lee K; Little W; Tang A; Levya F; Momomura S; Manrodt C; Bergemann T; Cowie MR
    Int J Cardiol; 2016 Jan; 202():349-55. PubMed ID: 26426276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
    Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Review of Left Bundle Branch Block in the Failing Heart - Pathogenesis, Prognosis, and Therapy.
    Kanawati J; Sy RW
    Heart Lung Circ; 2018 Mar; 27(3):291-300. PubMed ID: 29097067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
    Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
    Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study.
    Huntjens PR; Walmsley J; Ploux S; Bordachar P; Prinzen FW; Delhaas T; Lumens J
    Europace; 2014 Nov; 16 Suppl 4():iv62-iv68. PubMed ID: 25362172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
    Rickard J; Bassiouny M; Cronin EM; Martin DO; Varma N; Niebauer MJ; Tchou PJ; Tang WH; Wilkoff BL
    Am J Cardiol; 2011 Dec; 108(11):1576-80. PubMed ID: 21890086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations.
    Galeotti L; van Dam PM; Loring Z; Chan D; Strauss DG
    Europace; 2013 Dec; 15(12):1816-21. PubMed ID: 23703366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.
    Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival with cardiac-resynchronization therapy in mild heart failure.
    Goldenberg I; Kutyifa V; Klein HU; Cannom DS; Brown MW; Dan A; Daubert JP; Estes NA; Foster E; Greenberg H; Kautzner J; Klempfner R; Kuniss M; Merkely B; Pfeffer MA; Quesada A; Viskin S; McNitt S; Polonsky B; Ghanem A; Solomon SD; Wilber D; Zareba W; Moss AJ
    N Engl J Med; 2014 May; 370(18):1694-701. PubMed ID: 24678999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Electrophysiologic and Hemodynamic Effects of Cardiac Resynchronization Therapy: From Bench to Bedside and Vice Versa.
    Schreurs R; Wiegerinck RF; Prinzen FW
    Heart Fail Clin; 2017 Jan; 13(1):43-52. PubMed ID: 27886931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transseptal conduction as an important determinant for cardiac resynchronization therapy, as revealed by extensive electrical mapping in the dyssynchronous canine heart.
    Strik M; van Deursen CJ; van Middendorp LB; van Hunnik A; Kuiper M; Auricchio A; Prinzen FW
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):682-9. PubMed ID: 23873141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.